UBS AM’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-918,197
Closed -$32.8M 2669
2014
Q4
$32.8M Buy
918,197
+124,800
+16% +$3.73M 0.03% 553
2014
Q3
$20.6M Buy
793,397
+505,900
+176% +$14.5M 0.02% 672
2014
Q2
$9.5M Buy
287,497
+248,700
+641% +$7.18M 0.01% 869
2014
Q1
$1.16M Buy
38,797
+5,100
+15% +$176K ﹤0.01% 1517
2013
Q4
$1.02M Sell
33,697
-100
-0.3% -$2.75K ﹤0.01% 1514
2013
Q3
$1.07M Sell
33,797
-262,100
-89% -$6.01M ﹤0.01% 1477
2013
Q2
$4.47M Buy
+295,897
New +$4.1M 0.01% 986

Other funds holding NPSP

UBS AM's NPSP Position: Q1 2015 in Review

UBS AM sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 918,197 shares — an estimated $32.8M sold.

UBS AM first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $32.8M in Q4 2014. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

  • UBS AM reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • UBS AM sold 918,197 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $32.8M.
  • UBS AM first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • UBS AM's NPS PHARMACEUTICALS INC position peaked at $32.8M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on UBS AM's 13F filing for Q1 2015, filed 4 May 2015.